There are still other anti-cancer agents which target cells proliferation pathways, involving mitogen activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) / serine-threonine kinase (Akt) pathway 8, 9. The gene discussed is AKT1; the disease is cancer.